<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="3c5dad7d-4db2-4615-92cb-01ea4d769adf"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Cyclomydril<sup>Â®</sup>
      <br/>(cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) Sterile</title>
   <effectiveTime value="20250515"/>
   <setId root="8268b70f-3f10-48dd-bb24-baaeb27a1325"/>
   <versionNumber value="13"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="008018525" root="1.3.6.1.4.1.519.1"/>
            <name>Alcon Laboratories, Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="007672236" root="1.3.6.1.4.1.519.1"/>
                        <name>Alcon Research LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="manufacture"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0065-0359" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="e569b0b6-dfba-457d-8ea2-999293ae3659"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20231214"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0065-0359" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Cyclomydril</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>cyclopentolate hydrochloride and phenylephrine hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="2"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="736I6971TE" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CYCLOPENTOLATE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="I76F4SHP7J" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CYCLOPENTOLATE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="10"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="04JA59TNSJ" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PHENYLEPHRINE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="1WS297W6MV" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>PHENYLEPHRINE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="F5UM2KM3W7" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZALKONIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="7FLD91C86K" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>EDETATE DISODIUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="R57ZHV85D4" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="45P3261C7T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CARBONATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="2"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="0065-0359-02" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19580630"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="5"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="0065-0359-05" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19580630"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA084300" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19580630"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <component>
                  <observationMedia ID="SPLSERV-9b7f1835-05fa-425d-b29a-f5e58bbafa99">
                     <text>Carton Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="300048632 C CYCMYD 5ml US.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="SPLSERV-9079da02-6ec6-4501-a909-d3926321473f">
                     <text>label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="300048631 L CYCLOMYD 5ml US.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_35901c63-46b9-42e9-81e1-4c5978fdd4ee">
               <id root="865fe28d-953d-4bed-b1b5-b4686b30a036"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title mediaType="text/x-hl7-title+xml">DESCRIPTION</title>
               <text>
                  <paragraph>CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) is a mydriatic prepared as a sterile topical ophthalmic solution. The active ingredients are represented by the chemical structures:</paragraph>
                  <renderMultiMedia referencedObject="SPLSERV-cf28d6f9-ac19-430a-9b93-c288e02c2aaa"/>
                  <paragraph>
                     <content styleCode="bold">Established Name:</content>
                     <br/>Cyclopentolate Hydrochloride						</paragraph>
                  <paragraph>
                     <content styleCode="bold">Chemical Name:</content>
                     <br/>2-(Dimethylamino)ethyl 1 - hydroxy-Î±-phenylcyclopentaneacetate hydrochloride)						</paragraph>
                  <paragraph>
                     <content styleCode="bold">Molecular Formula:</content>
                     <br/>C<sub>17</sub>H<sub>25</sub>NO<sub>3 </sub>â¢ HCl</paragraph>
                  <paragraph>
                     <content styleCode="bold">Molecular Weight:</content>
                     <br/>327.85 g/mol</paragraph>
                  <renderMultiMedia referencedObject="SPLSERV-e9e1f1c1-dc20-4fef-a493-68089afaea7a"/>
                  <paragraph>
                     <content styleCode="bold">Established Name:</content>
                     <br/>Phenylephrine Hydrochloride						</paragraph>
                  <paragraph>
                     <content styleCode="bold">Chemical Name:</content>
                     <br/>3-hydroxy-Î±[(methylamino)-methyl]-, Benzenemethanol,  hydrochloride (R)-.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Molecular Formula:</content>
                     <br/>C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub> â¢ HCl</paragraph>
                  <paragraph>
                     <content styleCode="bold">Molecular Weight:</content>
                     <br/>203.67 g/mol</paragraph>
                  <paragraph>Each mL of CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) contains:<br/>
                     <content styleCode="bold">Active: </content>cyclopentolate hydrochloride 0.2%, phenylephrine hydrochloride 1%. <content styleCode="bold">Preservative: </content>benzalkonium chloride 0.01%.<br/>
                     <content styleCode="bold">Inactives: </content>edetate disodium, boric acid, hydrochloric acid and /or sodium carbonate (to adjust pH), purified water.</paragraph>
               </text>
               <effectiveTime value="20250515"/>
               <component>
                  <observationMedia ID="SPLSERV-cf28d6f9-ac19-430a-9b93-c288e02c2aaa">
                     <text>cyclopentolate hydrochloride</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="chemical.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="SPLSERV-e9e1f1c1-dc20-4fef-a493-68089afaea7a">
                     <text>phenylephrine hydrochloride</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="chemical-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_0cb02fc1-0937-40d6-a7b0-94725911d7b5">
               <id root="490d7936-1ec0-4e1e-9705-c03568093580"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title mediaType="text/x-hl7-title+xml">CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Cyclopentolate hydrochloride is an anticholinergic drug and phenylephrine hydrochloride is an adrenergic drug. This combination induces mydriasis that is greater than that of either drug alone at its respective concentration. The concentrations of cyclopentolate hydrochloride and phenylephrine hydrochloride have been selected to induce mydriasis with little accompanying cycloplegia. Heavily pigmented irides may require more doses than lightly pigmented irides.</paragraph>
               </text>
               <effectiveTime value="20180629"/>
            </section>
         </component>
         <component>
            <section ID="ID_de1eef70-77c5-411a-9a06-41b0db198224">
               <id root="36e96989-a9e5-4760-a033-1ffbaf7799eb"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title mediaType="text/x-hl7-title+xml">INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>For the production of mydriasis.</paragraph>
               </text>
               <effectiveTime value="20110803"/>
            </section>
         </component>
         <component>
            <section ID="ID_9a72b524-9989-4c6f-af5c-4a4c1f697986">
               <id root="edf62844-9ff9-4362-a612-5697a2d6b25b"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title mediaType="text/x-hl7-title+xml">CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Do not use in patients with hypersensitivity to any component of this preparation.</paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_f8d4dcb9-ebc7-4827-8058-a766ef959c72">
               <id root="172c4ba6-c454-47f5-89a5-0611b3d5c002"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title mediaType="text/x-hl7-title+xml">WARNINGS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION.Â </content>There have been reports of serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions, in patients using higher concentrations of phenylephrine. These episodes, some fatal, have usually occurred in patients with pre-existing cardiovascular diseases. This preparation may cause central nervous system (CNS) disturbances. This is especially true in younger age groups, but may occur at any age, especially with the stronger solutions. Infants are especially prone to CNS and cardiopulmonary side effects from cyclopentolate.</paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_16931ca4-1016-4639-8c14-23149e5d44a5">
               <id root="83e6afcb-f4a3-45be-be0d-6fa86c42fbcd"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title mediaType="text/x-hl7-title+xml">PRECAUTIONS</title>
               <effectiveTime value="20250515"/>
               <component>
                  <section ID="ID_8a0e59b7-598f-466d-8bcd-70d50ecc9a76">
                     <id root="a3bf8ee7-1504-4cb0-9621-e48963b4fa92"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">General</title>
                     <text>
                        <paragraph>Caution should be observed when considering use of this medication in the presence of Down's syndrome due to potential increased sensitivity to anticholinergics. This product should be used with caution in patients at risk for angle closure due to the potential to precipitate acute angle closure. Because of the risk of provoking hyperthermia, use with caution in patients, especially children, who may be exposed to elevated environmental temperatures or who are febrile.Â  The use of phenylephrine in the eye may liberate pigment granules from the iris. Mydriatics may produce a transient elevation of intraocular pressure.</paragraph>
                     </text>
                     <effectiveTime value="20250515"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_35dfa2c3-0310-4469-b994-638ecf85447d">
                     <id root="40398c9c-5a76-4cea-a63a-7cea66983f0a"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Information for Patients</title>
                     <text>
                        <paragraph>Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in hazardous activities while pupils are dilated. Patient may experience sensitivity to light.</paragraph>
                     </text>
                     <effectiveTime value="20250515"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_ee1c97c0-ccfb-4b75-800a-a8882321a181">
                     <id root="a39a0f28-2969-439b-bf48-71d716e7732b"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>There have been no long-term studies done using cyclopentolate hydrochloride and/or phenylephrine hydrochloride in animals to evaluate carcinogenic potential.</paragraph>
                     </text>
                     <effectiveTime value="20110803"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_7e075756-ba87-478b-8fb3-3ca8c3072839">
                     <id root="fdb47bcd-61e7-4c6a-9f7f-35cd6328416f"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Pregnancy</title>
                     <text>
                        <paragraph>Animal reproduction studies have not been conducted with cyclopentolate hydrochloride and/or phenylephrine hydrochloride. It is also not known whether cyclopentolate hydrochloride and/or phenylephrine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) should be given to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20180629"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_7bcf01d9-1ee9-4acc-837d-0bf0cc718c45">
                     <id root="e72a027a-9f53-434c-be8c-1c18a486bb28"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether these drugs are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20180629"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_23f9e0ba-28e1-4d43-9464-efee08ce1c5f">
                     <id root="85deefb0-586a-4a8f-86d8-8d689ec9c68f"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Pediatric Use</title>
                     <text>
                        <paragraph>Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances in pediatric patients. Increased susceptibility to cyclopentolate has been reported in infants, young children, and in children with spastic paralysis or brain damage. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place. Feeding intolerance may follow ophthalmic use of this product in infants. It is recommended that feeding be withheld after administration, and to observe infants closely for at least 30 minutes (see <content styleCode="bold">PRECAUTIONS</content>).</paragraph>
                     </text>
                     <effectiveTime value="20250515"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_8b5cdd88-8e52-4f33-9b40-1a782d028c8f">
                     <id root="b6660992-c919-46aa-a301-776fb13c0230"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title mediaType="text/x-hl7-title+xml">Geriatric Use</title>
                     <text>
                        <paragraph>No overall differences in safety or effectiveness have been observed between elderly and younger patients.</paragraph>
                     </text>
                     <effectiveTime value="20110803"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2352be3a-dfe3-4087-a297-8822e2272199">
               <id root="faaf20cd-a2c4-4d4d-9941-0ceb910aaca8"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title mediaType="text/x-hl7-title+xml">ADVERSE REACTIONS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Ocular</content>
                  </paragraph>
                  <paragraph>The following ocular adverse experiences have been associated with the use of CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution): increased intraocular pressure, burning/irritation upon instillation, photophobia, blurred vision and superficial punctate keratitis.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Nonocular</content>
                  </paragraph>
                  <paragraph>Use of cyclopentolate hydrochloride has been associated with psychotic reactions and behavioral disturbances in children. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place. This drug produces reactions similar to those of other adrenergic and anticholinergic drugs; however, the central nervous system manifestations as noted above are most common. Other manifestations of adrenergic and anticholinergic topical ophthalmic drugs include tachycardia, hyperpyrexia, hypertension, vasodilation, urinary retention, diminished gastrointestinal motility, convulsion, bradycardia, apnea, necrotizing colitis and abdominal distention (in newborns and especially premature infants), skin rash, drowsiness, and decreased secretion in salivary and sweat glands, pharynx, bronchi and nasal passages. Severe manifestations of toxicity include coma, medullary paralysis and death.Â Systemic toxicity can result from topical application of sympathomimetic drugs: headache, blood pressure elevation, extrasystoles, tachycardia, syncope and cerebrovascular accidents have been reported.</paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_c0a42324-fb93-45db-8ef8-cb2c76c4bb05">
               <id root="36a9f793-6fc0-4166-b98b-eec49f0cae0a"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title mediaType="text/x-hl7-title+xml">OVERDOSAGE</title>
               <text>
                  <paragraph>Excessive dosage may produce behavioral disturbances, tachycardia, hyperpyrexia, hypertension, elevated intraocular pressure, vasodilation, urinary retention, diminished gastrointestinal motility and decreased secretion in salivary and sweat glands, pharynx, bronchi and nasal passages. Pulmonary oedema or cardiac arrest may occur due to phenylephrine toxicity.Â  Severe intoxication is characterized by central nervous system depression, coma, circulatory and respiratory failure, and death. <br/>Patients exhibiting signs of overdosage should receive supportive care and monitoring.</paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_d44949f0-ea71-4af6-b0d9-f913fed3be1c">
               <id root="45723d2b-1a73-41bf-8794-e938890e26ee"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title mediaType="text/x-hl7-title+xml">DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>Instill one drop in each eye every five to ten minutes. To minimize systemic absorption, apply pressure over the nasolacrimal sac for two to three minutes following instillation. Observe infants closely for at least 30 minutes.</paragraph>
               </text>
               <effectiveTime value="20110803"/>
            </section>
         </component>
         <component>
            <section ID="ID_ea48248c-8196-4181-ae8e-5e8b53f88483">
               <id root="fa7b313b-b59f-4639-82ac-7fa8696bd330"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title mediaType="text/x-hl7-title+xml">HOW SUPPLIED</title>
               <text>
                  <paragraph>CYCLOMYDRIL<sup>Â®</sup> (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) is supplied as a sterile solution in 2 mL and 5 mL, in plastic DROP-TAINERÂ® dispensers.</paragraph>
                  <paragraph>2 mLÂ Â Â Â Â Â Â Â Â Â  NDC 0065-0359-02</paragraph>
                  <paragraph>5 mLÂ Â Â Â Â Â Â Â Â Â  NDC 0065-0359-05</paragraph>
                  <paragraph>
                     <content styleCode="bold">Storage: </content>Store at 8Â°C to 25Â°C (46Â°F - 77Â°F)</paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_20404684-396a-4f63-8071-2f145af1d78c">
               <id root="0ad425b6-2ee2-45a2-ab8a-0bcb7264b7c3"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <br/>
                  <paragraph>Distributed by:<br/>ALCON LABORATORIES, INC. <br/>6201 South Freeway <br/>Fort Worth, Texas 76134-2099</paragraph>
                  <paragraph>Â© 2025 Alcon Inc.</paragraph>
                  <br/>
                  <paragraph>Revised: May 2025.<br/>
                     <br/>300065206-1223 </paragraph>
               </text>
               <effectiveTime value="20250515"/>
            </section>
         </component>
         <component>
            <section ID="ID_22556aca-3aa6-4273-8a60-457f8d3f5a15">
               <id root="687bdcde-5265-4dff-ba65-5c86a7d6cddc"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title mediaType="text/x-hl7-title+xml">PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NDC </content>0065-0359-05<br/>
                     <br/>
                     <content styleCode="bold">Alcon</content>
                     <br/>
                     <content styleCode="bold">Cyclomydril<sup>Â®</sup>
                        <br/>
                     </content>(cyclopentolate <br/>hydrochloride, <br/>phenylephrine <br/>hydrochloride <br/>ophthalmic <br/>solution)<br/>
                     <br/>
                     <content styleCode="bold">5 mL Sterile<br/>
                     </content>
                     <br/>
                     <content styleCode="bold">Rx Only<br/>
                     </content>
                     <br/>Sterile Ophthalmic Solution<br/>
                     <br/>
                     <content styleCode="bold">USUAL DOSAGE: </content>Instill one drop <br/>in each eye every five to ten <br/>minutes. Read enclosed insert.<br/>
                     <br/>
                     <content styleCode="bold">FOR TOPICAL OPHTHALMIC USE <br/>ONLY<br/>
                     </content>
                     <br/>
                     <content styleCode="bold">WARNING: </content>Do not touch <br/>dropper tip to any surface as <br/>this may contaminate the <br/>solution.<br/>
                     <br/>
                     <content styleCode="bold">INGREDIENTS: Each mL <br/>contains: Active: <br/>
                     </content>cyclopentolate hydrochloride <br/>0.2%, phenylephrine <br/>hydrochloride 1%. <br/>
                     <content styleCode="bold">Preservative: </content>benzalkonium <br/>chloride 0.01%. <content styleCode="bold">Inactives: <br/>
                     </content>edetate disodium, boric acid, <br/>hydrochloric acid and/or <br/>sodium carbonate (to adjust <br/>pH), purified water.<br/>
                     <br/>
                     <content styleCode="bold">STORAGE: </content>Store at 8Â°-25Â° C<br/> (46Â° to 77Â° F).<br/>
                     <br/>
                     <content styleCode="bold">Alcon<br/>
                     </content>
                     <br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC. <br/>
                     </content>Fort Worth, Texas 76134 USA <br/>Printed in USA<br/>
                     <br/>SN:<br/>LOT:<br/>EXP.:<br/>GTIN:Â 00300650359054<br/>
                     <br/>
                     <br/>
                     <content styleCode="bold">300048632-0821 </content>
                  </paragraph>
                  <renderMultiMedia referencedObject="SPLSERV-9b7f1835-05fa-425d-b29a-f5e58bbafa99"/>
                  <paragraph>
                     <content styleCode="bold">NDC </content>0065-0359-05<br/>
                     <br/>
                     <content styleCode="bold">Alcon</content>
                     <br/>
                     <content styleCode="bold">Cyclomydril<sup>Â®</sup>
                        <br/>
                     </content>
                     <content styleCode="bold">(cyclopentolate <br/>hydrochloride, <br/>phenylephrine <br/>hydrochloride <br/>ophthalmic <br/>solution)<br/>
                        <br/>
                     </content>Sterile<content styleCode="bold"> 5 mL <br/>
                     </content>
                     <br/>
                     <content styleCode="bold">Rx Only</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">INGREDIENTS: Each mL contains: Actives: </content>cyclopentolate <br/>hydrochloride 0.2%, phenylephrine hydrochloride 1%. <br/>
                     <content styleCode="bold">Preservative:</content> benzalkonium chloride 0.01%.<content styleCode="bold"> Inactives:</content>
                     <br/>edetate disodium, boric acid, hydrochloric acid and/or <br/>sodium carbonate (to adjust pH), purified water.<br/>
                     <br/>
                     <content styleCode="bold">WARNING:Â </content>Do not touch dropper tip to any surface as this <br/>may contaminate the solution. <br/>
                     <br/>
                     <content styleCode="bold">USUAL DOSAGE: </content>Instill one drop in each eye every five to <br/>ten minutes. Read enclosed insert.<br/>
                     <br/>
                     <content styleCode="bold">STORAGE:Â </content>Store at 8Â°-25Â° C (46Â° to 77Â° F). <br/>
                     <br/>Printed in USA<br/>
                     <br/>
                     <content styleCode="bold">ALCON LABORATORIES, INC. <br/>
                     </content>Fort Worth, Texas 76134 USA <br/>
                     <br/>LOT:<br/>
                     <br/>EXP.:<br/>
                     <br/>
                     <content styleCode="bold">300048631-0821 </content>
                     <br/>
                     <br/>
                  </paragraph>
                  <renderMultiMedia referencedObject="SPLSERV-9079da02-6ec6-4501-a909-d3926321473f"/>
               </text>
               <effectiveTime value="20231214"/>
            </section>
         </component>
      </structuredBody>
   </component>
</document>